Socioeconomic status and long-term risk of inflammatory bowel disease: a prospective cohort study with mediation analysis
Journal of Global Health · 06.11.2026 · 16
DOI: 10.7189/jogh.16.04391 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Global Health, online erschienen am 06.11.2026. Verfasst von Qian Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Social Class. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
- State Key Laboratory of Digestive Health, Beijing, China.
- National Clinical Research Center for Digestive Diseases, Beijing, China.
- Beijing Key Laboratory of Early Gastrointestinal Cancer Medicine and Medical Devices, Beijing, China.
Zitieren
APA
Zhang, Q., Wang, Y., Yu, S., Zhou, Y., Liu, S., Li, P., Zhang, S., & Wu, S. (2026). Socioeconomic status and long-term risk of inflammatory bowel disease: a prospective cohort study with mediation analysis. Journal of Global Health, 16. https://doi.org/10.7189/jogh.16.04391
Vancouver
Zhang Q, Wang Y, Yu S, Zhou Y, Liu S, Li P, et al. Socioeconomic status and long-term risk of inflammatory bowel disease: a prospective cohort study with mediation analysis. Journal of Global Health. 2026;16. doi:10.7189/jogh.16.04391
BibTeX
@article{Zhang2026,
author = {Zhang, Qian and Wang, Yutao and Yu, Shuang and Zhou, Yesheng and Liu, Si and Li, Peng and Zhang, Shutian and Wu, Shanshan},
title = {Socioeconomic status and long-term risk of inflammatory bowel disease: a prospective cohort study with mediation analysis},
journal = {Journal of Global Health},
year = {2026},
volume = {16},
doi = {10.7189/jogh.16.04391}
}
EUVIMED